Voyager Therapeutics Stock In The News

VYGR Stock  USD 3.90  0.17  4.18%   
Our overall analysis of Voyager Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Voyager Therapeutics. The specific impact of Voyager Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Voyager Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Voyager Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Voyager Therapeutics Backtesting and Voyager Therapeutics Hype Analysis.
To learn how to invest in Voyager Stock, please use our How to Invest in Voyager Therapeutics guide.

Voyager Therapeutics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
https://www.globenewswire.com/news-release/2025/03/11/3040977/36461/en/Voyager-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-and-Operating-Results.html
 Bullish
Macroaxis News: globenewswire.com
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
https://www.globenewswire.com/news-release/2025/03/04/3036316/36461/en/Voyager-Therapeutics-Announces-Fourth-Quarter-2024-Conference-Call-and-Webcast.html
 Neutral
Macroaxis News: globenewswire.com
Voyager Reports Positive Topline Data fo...
https://www.globenewswire.com/news-release/2025/03/03/3035441/36461/en/Voyager-Reports-Positive-Topline-Data-for-Single-Ascending-Dose-SAD-Trial-of-Anti-Tau-Antibody-VY7523-and-Initiates-Multiple-Ascending-Dose-MAD-Trial-in-Alzheimer-s-Disease.html
 Neutral
Macroaxis News: globenewswire.com
VOYAGER ALERT: Bragar Eagel & Squire, P....
https://www.globenewswire.com/news-release/2025/02/25/3031636/0/en/VOYAGER-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Voyager-Therapeutics-Inc-on-Behalf-of-Voyager-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html
 Neutral
Macroaxis News: globenewswire.com
Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. (VYGR) on Behalf of Investors
https://www.globenewswire.com/news-release/2025/02/19/3029241/937/en/Kirby-McInerney-LLP-Announces-Investigation-Against-Voyager-Therapeutics-Inc-VYGR-on-Behalf-of-Investors.html
 Bullish
Yahoo News
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
https://finance.yahoo.com/news/voyager-enters-license-next-generation-120000608.html
 Bullish
Yahoo News
7 Biotech Stocks to Buy for Their Game-Changing Potential
https://finance.yahoo.com/news/7-biotech-stocks-buy-game-100000015.html
 Neutral
Yahoo News
Neurocrine Biosciences Is Pioneering Therapies for Neurological Disorders
https://finance.yahoo.com/news/neurocrine-biosciences-pioneering-therapies-neurological-140001407.html
 Bullish
Yahoo News
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
https://finance.yahoo.com/news/12-most-undervalued-biotech-stocks-180928477.html
 Bullish
Yahoo News
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
https://finance.yahoo.com/news/7-under-radar-biotech-stocks-202023313.html
 Bullish

Voyager Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Voyager and other traded companies coverage with news coverage. We help investors stay connected with Voyager headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Voyager Stock performance. Please note that trading solely based on the Voyager Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Voyager Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Voyager Therapeutics investors visualize upcoming and past events in order to time the market based on Voyager Therapeutics noise-free hype analysis.
Voyager Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Voyager earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Voyager Therapeutics that are available to investors today. That information is available publicly through Voyager media outlets and privately through word of mouth or via Voyager internal channels. However, regardless of the origin, that massive amount of Voyager data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Voyager Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Voyager Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Voyager Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Voyager Therapeutics alpha.

Voyager Largest EPS Surprises

Earnings surprises can significantly impact Voyager Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-08-03
2023-06-30-0.57-0.510.0610 
2023-03-07
2022-12-31-0.55-0.61-0.0610 
2016-11-10
2016-09-30-0.41-0.350.0614 
2021-05-10
2021-03-31-0.66-0.580.0812 
2021-08-09
2021-06-30-0.71-0.8-0.0912 
2016-05-12
2016-03-31-0.38-0.290.0923 
View All Earnings Estimates

Voyager Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Voyager Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News
13th of March 2025
Acquisition by Sandrock Alfred of 145000 shares of Voyager Therapeutics subject to Rule 16...
at MacroaxisInsider 
Yahoo News
11th of March 2025
Voyager Therapeutics Q4 Earnings Snapshot
at finance.yahoo.com 
Yahoo News
4th of March 2025
New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer...
at finance.yahoo.com 
Macroaxis News: globenewswire.com
3rd of March 2025
Voyager Reports Positive Topline Data for Single Ascending Dose Trial of Anti-Tau Antibody...
at globenewswire.com 
Macroaxis News: globenewswire.com
25th of February 2025
VOYAGER ALERT Bragar Eagel Squire, P.C. is Investigating Voyager Therapeutics, Inc. on Beh...
at globenewswire.com 
Google News at Macroaxis
24th of February 2025
Acquisition by Robin Swartz of 71250 shares of Voyager Therapeutics subject to Rule 16b-3
at news.google.com 
businesswire News
20th of February 2025
Disposition of 3894 shares by Robin Swartz of Voyager Therapeutics at 4.25 subject to Rule...
at businesswire.com 
Google News at Macroaxis
13th of February 2025
What is Wedbushs Estimate for VYGR FY2029 Earnings - MarketBeat
at news.google.com 
Macroaxis News
11th of February 2025
Disposition of 4358 shares by Fahey Sandell Jacquelyn of Voyager Therapeutics at 4.45 subj...
at MacroaxisInsider 
Google News at Macroaxis
7th of January 2025
Trend Tracker for - Stock Traders Daily
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Voyager Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Voyager Therapeutics' short interest history, or implied volatility extrapolated from Voyager Therapeutics options trading.

Additional Tools for Voyager Stock Analysis

When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.